Bell Rock Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-50
Closed -$5K 358
2019
Q4
$5K Hold
50
﹤0.01% 332
2019
Q3
$5K Hold
50
﹤0.01% 320
2019
Q2
$8K Hold
50
0.01% 313
2019
Q1
$8K Hold
50
﹤0.01% 345
2018
Q4
$4K Hold
50
﹤0.01% 385
2018
Q3
$9K Hold
50
﹤0.01% 365
2018
Q2
$7K Hold
50
﹤0.01% 390
2018
Q1
$6K Buy
+50
New +$6.29K ﹤0.01% 398
2017
Q2
Sell
-35
Closed -$4K 431
2017
Q1
$4K Hold
35
﹤0.01% 329
2016
Q4
$4K Buy
+35
New +$4.21K ﹤0.01% 322

Other funds holding GWPH

Bell Rock Capital's GWPH Position: Q1 2020 in Review

Bell Rock Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2020, closing a stake of 50 shares — an estimated $5K sold.

Bell Rock Capital first reported a position in GWPH in Q4 2016 and held it in 10 quarters. The position peaked at $9K in Q3 2018. 289 funds tracked by Wall St. Rank hold GWPH as of Q1 2020.

  • Bell Rock Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • Bell Rock Capital sold 50 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2020, an estimated $5K.
  • Bell Rock Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 10 quarters.
  • Bell Rock Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9K in Q3 2018.
  • 289 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.